SomaLogic is an industry leader in high-plex proteomics advancing life science research and human health. Our pioneering SomaScan® platform provides more coverage of the proteome than any other technology, detecting up to 11,000 proteins in a variety of biological samples for biomarker discovery and development. With broad coverage of the proteome, the SomaScan Assay, driven by SOMAmer® reagents (Slow Off-Rate Modified Aptamers) delivers data with high throughput, high specificity, and unmatched reproducibility to advance your research with confidence. SomaScan Assay services are also available as custom and disease specific panels to study a subset of proteins for your specific research needs. In addition to biomarker discovery and development, SomaSignal® Tests deliver medical insights across 21 clinically validated areas such as cardiovascular and liver function, turning proteomic insights into actionable health information. SomaLogic provides the SomaScan® Assay, a fee-for-service proteomic technology platform, performed in a CLIA-certified lab. Our team of experts manage all the steps from sample intake, processing to data delivery — collaborating to achieve new biological insights and discover biomarkers and signatures from your precious samples. Whether you’re conducting a small academic study or a large clinical trial, we can handle your samples of various types including plasma, serum, CSF, urine, and more!